Carazolol

Carazolol is a high affinity inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.[1]

Carazolol
Clinical data
AHFS/Drugs.comInternational Drug Names
ATCvet code
Identifiers
IUPAC name
  • 1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.055.387
Chemical and physical data
FormulaC18H22N2O2
Molar mass298.38 g·mol−1
3D model (JSmol)
SMILES
  • OC(CNC(C)C)COc3cccc2c3c1c(cccc1)[nH]2

References
  1. Innis RB, Corrēa FM, Synder SH (1979). "Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes". Life Sci. 24 (24): 2255–64. doi:10.1016/0024-3205(79)90102-4. PMID 41147.
  • Carazolol at the US National Library of Medicine Medical Subject Headings (MeSH)


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.